These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat. Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185 [TBL] [Abstract][Full Text] [Related]
9. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Akerman S; Kaube H; Goadsby PJ Br J Pharmacol; 2003 Oct; 140(4):718-24. PubMed ID: 14534154 [TBL] [Abstract][Full Text] [Related]
10. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models. Haanes KA; Labastida-Ramírez A; Blixt FW; Rubio-Beltrán E; Dirven CM; Danser AH; Edvinsson L; MaassenVanDenBrink A Cephalalgia; 2019 Oct; 39(11):1421-1434. PubMed ID: 31104506 [TBL] [Abstract][Full Text] [Related]
11. Modulation of nociceptive dural input to the trigeminocervical complex through GluK1 kainate receptors. Andreou AP; Holland PR; Lasalandra MP; Goadsby PJ Pain; 2015 Mar; 156(3):439-450. PubMed ID: 25679470 [TBL] [Abstract][Full Text] [Related]
12. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine. Gupta S; Akerman S; van den Maagdenberg AM; Saxena PR; Goadsby PJ; van den Brink AM Cephalalgia; 2006 Nov; 26(11):1294-303. PubMed ID: 17059436 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. Weiss B; Alt A; Ogden AM; Gates M; Dieckman DK; Clemens-Smith A; Ho KH; Jarvie K; Rizkalla G; Wright RA; Calligaro DO; Schoepp D; Mattiuz EL; Stratford RE; Johnson B; Salhoff C; Katofiasc M; Phebus LA; Schenck K; Cohen M; Filla SA; Ornstein PL; Johnson KW; Bleakman D J Pharmacol Exp Ther; 2006 Aug; 318(2):772-81. PubMed ID: 16690725 [TBL] [Abstract][Full Text] [Related]